Profile
Full Name
Humacyte, Inc.Ticker Symbol
HUMAExchange
NASDAQSector
HealthcareIndustry
BiotechnologyCountry
United StatesIPO
December 1, 2020Indexes
Not includedWebsite
http://humacyte.comEmployees
218Key Details
Price
$1.55(+0.65%)
Market cap
$240.43M(Small cap)
Last Dividend
-
TTM Dividend yield
-
Annual revenue
-
Annual EPS
-$1.26(-17.76% YoY)
PE ratio
-
Next earnings date
May 9, 2025Next ex-dividend date
N/ANext split date
N/APrice
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Price Performance
Price Range
Capitalization
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Market cap
Shares Outstanding
Technical Indicators
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Dividend
Humacyte doesn't have historical dividend data
Income Statement
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Revenue
EPS
Profit
Expenses
EBIT & EBITDA
Balance Sheet
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Assets
Liabilities
Debt
Equity & Capital
Cash Flow Statement
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Cashflow Activities
CAPEX
Free Cash Flow
Profitability Ratios
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Margins
ROA & ROE
Valuation
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PE Ratio
PB Ratio
PS Ratio
Enterprise value
EV/EBITDA
Financial Health
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Liquidity
Leverage
Risk & Stability
Analyst ratings
Recent major analysts updates
Mar 31, 25 D. Boral Capital
BuyMar 28, 25 D. Boral Capital
BuyMar 26, 25 D. Boral Capital
BuyMar 12, 25 HC Wainwright & Co.
BuyMar 7, 25 D. Boral Capital
BuyFeb 27, 25 D. Boral Capital
BuyFeb 27, 25 Benchmark
BuyFeb 26, 25 D. Boral Capital
BuyJan 21, 25 D. Boral Capital
BuyJan 13, 25 D. Boral Capital
BuyInstitutional Ownership
- What is the ticker symbol for Humacyte?
- Does Humacyte pay dividends?
- What sector is Humacyte in?
- What industry is Humacyte in?
- What country is Humacyte based in?
- When did Humacyte go public?
- Is Humacyte in the S&P 500?
- Is Humacyte in the NASDAQ 100?
- Is Humacyte in the Dow Jones?
- When was Humacyte's last earnings report?
- When does Humacyte report earnings?
- Should I buy Humacyte stock now?
What is the ticker symbol for Humacyte?
The ticker symbol for Humacyte is NASDAQ:HUMA
Does Humacyte pay dividends?
No, Humacyte does not pay dividends
What sector is Humacyte in?
Humacyte is in the Healthcare sector
What industry is Humacyte in?
Humacyte is in the Biotechnology industry
What country is Humacyte based in?
Humacyte is headquartered in United States
When did Humacyte go public?
Humacyte's initial public offering (IPO) was on December 1, 2020
Is Humacyte in the S&P 500?
No, Humacyte is not included in the S&P 500 index
Is Humacyte in the NASDAQ 100?
No, Humacyte is not included in the NASDAQ 100 index
Is Humacyte in the Dow Jones?
No, Humacyte is not included in the Dow Jones index
When was Humacyte's last earnings report?
Humacyte's most recent earnings report was on Mar 28, 2025
When does Humacyte report earnings?
The next expected earnings date for Humacyte is May 9, 2025
Should I buy Humacyte stock now?
As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions